Krystal Biotech, Inc. (KRYS)

241.13 -1.85 (-0.76%) USD  |  NASDAQ  |  Dec 16, 15:04
More

Krystal Biotech Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade